Natco Pharma Shares Gain 2% Following US Pomalidomide Capsule Launch

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Natco Pharma Shares Soar 2% on US Launch of Pomalidomide Capsules

Natco Pharma

M

Moneycontrol•04-03-2026, 09:25

Natco Pharma Shares Soar 2% on US Launch of Pomalidomide Capsules

•Natco Pharma shares surged over 2% after launching Pomalidomide Capsules in the US market.
•The company, with Breckenridge Pharmaceutical, Inc., introduced the generic version of Celgene's Pomalyst.
•Pomalidomide Capsules treat multiple myeloma, AIDS-related Kaposi sarcoma, and HIV-negative Kaposi sarcoma.
•Available in 1 mg, 2 mg, 3 mg, 4 mg strengths, distributed via specialty pharmacies and clinics.
•CEO Rajeev Nannapaneni emphasized strengthening oncology portfolio and global accessibility of specialty medicines.

Read Full Article on Moneycontrol in English

✦

More like this

✦

More like this

Natco Pharma | Announces the launch of Pomalidomide Capsules in the US market used in the treatment of Adult patients with Multiple Myeloma. These capsules had estimated sales of $3.2 billion in the US for the 12 months that ended in September 2025.

Natco Pharma shares gain 3% on US launch of multiple myeloma drug

Representational image (Image: News18)

NATCO Pharma Launches Generic Blood Cancer Drug in US Market

Glenmark Pharma US Arm to Launch Sodium Phosphate Injection, Distribution Begins April

Glenmark Pharma US Arm to Launch Sodium Phosphate Injection, Distribution Begins April

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

Glenmark Pharma Targets 23% Core Margins by FY27, Strong Growth Across Markets

Glenmark Pharma Targets 23% Core Margins by FY27, Strong Growth Across Markets

Natco Pharma Shares Soar 11% on CDSCO Nod for Semaglutide Injection

Natco Pharma Shares Soar 11% on CDSCO Nod for Semaglutide Injection